These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1441476)

  • 21. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
    van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630
    [No Abstract]   [Full Text] [Related]  

  • 22. [Septomonab (Centoxin) in the treatment of gram-negative septicemia].
    Fomsgaard A
    Ugeskr Laeger; 1993 Apr; 155(14):1066-71. PubMed ID: 8497944
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
    Smith CR; Straube RC; Ziegler EJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies.
    Mehra IV; Gottlieb JE; Nash DB
    Pharmacotherapy; 1993; 13(2):128-34. PubMed ID: 8469619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy, safety, and therapeutic usage of HA-1A and E5 in the treatment of gram-negative sepsis.
    Quintiliani R; Cooper B; Maderazo E; Nightingale C
    Hosp Formul; 1992 Jan; 27(1):49-52, 54, 57-60. PubMed ID: 10116116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on monoclonal antibody therapy in the gram-negative sepsis syndrome.
    Hecker RB
    J Am Osteopath Assoc; 1992 Aug; 92(8):1017-20. PubMed ID: 1429060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one?
    Abad CL; Kumar A; Safdar N
    Crit Care Clin; 2011 Apr; 27(2):e1-27. PubMed ID: 21440195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroids for the treatment of septic shock.
    Sheagren JN
    Infect Dis Clin North Am; 1991 Dec; 5(4):875-82. PubMed ID: 1783773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.
    Periti P; Mazzei T
    Int J Antimicrob Agents; 1999 Jul; 12(2):97-105. PubMed ID: 10418753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centoxin.
    Davidson J; Tarlow M
    Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):121-2. PubMed ID: 8435673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Baumgartner JD
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):711-6. PubMed ID: 2261915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody against endotoxin.
    Zarowitz BJ
    DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues in the adjunct therapy of severe sepsis.
    Verhoef J; Hustinx WM; Frasa H; Hoepelman AI
    J Antimicrob Chemother; 1996 Aug; 38(2):167-82. PubMed ID: 8877531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.
    Hurley JC
    Drugs; 1994 Jun; 47(6):855-61. PubMed ID: 7521827
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal therapy for bacteremia and sepsis.
    Guglielmo J; Wiener-Kronish JP
    West J Med; 1992 Aug; 157(2):174. PubMed ID: 1441476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.